blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP0824695

EP0824695 - MONITORING IMMUNOTHERAPY OF MALIGNANT TUMOURS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  11.01.2003
Database last updated on 12.11.2024
Most recent event   Tooltip06.08.2004Lapse of the patent in a contracting state
New state(s): LU		published on 22.09.2004  [2004/39]
Applicant(s)For all designated states
Landstinget i Östergötland
Universitetssjukhuset
581 85 Linköping / SE
[1998/09]
Inventor(s)01 / HAKANSSON, Leif
Vikingstad Prästgard
S-290 50 Vikingstad / SE
[1998/09]
Representative(s)Petri, Stellan, et al
Ström & Gulliksson AB
P.O. Box 4188
203 13 Malmö / SE
[N/P]
Former [1998/09]Petri, Stellan, et al
Ström & Gulliksson AB Box 41 88
203 13 Malmö / SE
Application number, filing date96919761.510.05.1996
[1998/09]
WO1996EP02006
Priority number, dateSE1995000178012.05.1995         Original published format: SE 9501780
[1998/09]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9635948
Date:14.11.1996
Language:EN
[1996/50]
Type: A1 Application with search report 
No.:EP0824695
Date:25.02.1998
Language:EN
The application published by WIPO in one of the EPO official languages on 14.11.1996 takes the place of the publication of the European patent application.
[1998/09]
Type: B1 Patent specification 
No.:EP0824695
Date:06.03.2002
Language:EN
[2002/10]
Search report(s)International search report - published on:EP14.11.1996
ClassificationIPC:G01N33/50
[1998/09]
CPC:
G01N33/5091 (EP,US); G01N33/5011 (EP,US); G01N2800/52 (EP,US);
Y10S436/813 (EP,US)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1998/09]
TitleGerman:ÜBERWACHUNG DER IMMUNOTHERAPIE VON MALIGNEN TUMOREN[1998/09]
English:MONITORING IMMUNOTHERAPY OF MALIGNANT TUMOURS[1998/09]
French:SURVEILLANCE DE L'IMMUNOTHERAPIE DE TUMEURS MALIGNES[1998/09]
Entry into regional phase29.10.1997National basic fee paid 
29.10.1997Designation fee(s) paid 
29.10.1997Examination fee paid 
Examination procedure06.12.1996Request for preliminary examination filed
International Preliminary Examining Authority: EP
29.10.1997Examination requested  [1998/09]
23.11.1999Despatch of a communication from the examining division (Time limit: M04)
23.03.2000Reply to a communication from the examining division
27.06.2000Despatch of a communication from the examining division (Time limit: M04)
16.09.2000Reply to a communication from the examining division
04.04.2001Despatch of communication of intention to grant (Approval: Yes)
09.08.2001Communication of intention to grant the patent
13.11.2001Fee for grant paid
13.11.2001Fee for publishing/printing paid
Opposition(s)09.12.2002No opposition filed within time limit [2003/09]
Fees paidRenewal fee
07.05.1998Renewal fee patent year 03
12.05.1999Renewal fee patent year 04
02.05.2000Renewal fee patent year 05
07.05.2001Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT06.03.2002
BE06.03.2002
CH06.03.2002
FI06.03.2002
GR06.03.2002
LI06.03.2002
NL06.03.2002
IE10.05.2002
LU10.05.2002
MC10.05.2002
DK06.06.2002
PT06.06.2002
SE06.06.2002
ES25.09.2002
[2004/39]
Former [2004/04]AT06.03.2002
BE06.03.2002
CH06.03.2002
FI06.03.2002
GR06.03.2002
LI06.03.2002
NL06.03.2002
IE10.05.2002
MC10.05.2002
DK06.06.2002
PT06.06.2002
SE06.06.2002
ES25.09.2002
Former [2003/46]AT06.03.2002
BE06.03.2002
CH06.03.2002
FI06.03.2002
GR06.03.2002
LI06.03.2002
NL06.03.2002
IE10.05.2002
MC10.05.2002
DK06.06.2002
PT06.06.2002
SE06.06.2002
Former [2003/29]AT06.03.2002
BE06.03.2002
CH06.03.2002
FI06.03.2002
GR06.03.2002
LI06.03.2002
NL06.03.2002
IE10.05.2002
MC10.05.2002
PT06.06.2002
SE06.06.2002
Former [2003/25]AT06.03.2002
BE06.03.2002
CH06.03.2002
FI06.03.2002
GR06.03.2002
LI06.03.2002
NL06.03.2002
MC10.05.2002
PT06.06.2002
SE06.06.2002
Former [2003/19]AT06.03.2002
BE06.03.2002
CH06.03.2002
FI06.03.2002
GR06.03.2002
LI06.03.2002
NL06.03.2002
PT06.06.2002
SE06.06.2002
Former [2003/09]AT06.03.2002
BE06.03.2002
CH06.03.2002
FI06.03.2002
LI06.03.2002
NL06.03.2002
PT06.06.2002
SE06.06.2002
Former [2003/06]BE06.03.2002
CH06.03.2002
FI06.03.2002
LI06.03.2002
NL06.03.2002
PT06.06.2002
SE06.06.2002
Former [2003/01]CH06.03.2002
FI06.03.2002
LI06.03.2002
SE06.06.2002
Former [2002/49]FI06.03.2002
SE06.06.2002
Former [2002/37]SE06.06.2002
Cited inInternational search[Y]EP0238851  (IMREG INC [US]) [Y] 1-10 * the whole document *;
 [DY]  - T. TOGE ET AL., "Correlation between lymphocyte responsiveness to mitogens and results of chemo-immunotherapy in patiens with advanced cancer.", GANN, (1979), vol. 70, pages 699 - 703, XP000602920 [DY] 1-10 * the whole document *
 [Y]  - N. STANOJEVIC-BAKIC ET AL, "T-activin therapy in early stage melanoma patiens: in vitro and in vivo immunologic effect.", INTERNATIONAL JOURNAL OF THYMOLOGY, (19950101), vol. 3, no. 3, pages 265 - 272, XP000602849 [Y] 1-10 * the whole document *
 [DY]  - Y. KUROSU ET AL., "Indomethacin enhancement of lymphocyte responses to phytohemagglutinin in breast, stomach and colorectal cancer patients.", JAPANESE JOURNAL OF SURGERY, (1988), vol. 18, no. 2, pages 152 - 157, XP000602896 [DY] 1-10 * the whole document *
 [DA]  - C. C. WILHIDE ET AL., "An assay for monitoring response to therapy in cancer patients.", ANNALS OF CLINICAL AND LABORATORY SCIENCE, (1993), vol. 23, no. 3, pages 207 - 215, XP000602916
 [PA]  - R. CONDOTTI ET AL., "The novel immunomodulator, linomide, stimulates interleukin-2-induced human natural killer (NK) cell and PHA-stimulated T cell proliferation from normal donors.", LEUKEMIA RESEARCH, (199601), vol. 20, no. 1, pages 57 - 63, XP000602782

DOI:   http://dx.doi.org/10.1016/0145-2126(95)00110-7
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.